Long-term results of an endoscopic screening program for superficial esophageal cancer in patients with head and neck squamous cell carcinoma

Imagem de Miniatura
Arquivos
art_MOURA_Longterm_results_of_an_endoscopic_screening_program_for_2022.PDF (981.36 KB)
Citações na Scopus
Tipo de produção
article
Data de publicação
2022
DOI
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
GEORG THIEME VERLAG KG
Autores
KUBOKI, Yeda
Citação
ENDOSCOPY INTERNATIONAL OPEN, v.10, n.2, p.E200-E208, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background and study aims Patients with head and neck squamous cell carcinoma (HNSCC) are at risk of a second primary tumor in the gastrointestinal tract, most commonly in the esophagus. Screening these patients for esophageal carcinoma may help detect asymptomatic dysplasia and early cancer, thus allowing curative treatment and more prolonged survival, but the impact of endoscopic screening remains uncertain. Here we aimed to describe the long-term results of an esophageal SCC screening program in patients with head and neck cancer in terms of prevalence, associated risk factors, and survival. Patients and methods We performed an observational study of a prospectively collected database including patients with HNSCC who had undergone high-definition endoscopy with chromoscopy between 2010 and 2018 at a Brazilian tertiary academic center. Results The study included 1,888 patients. The esophageal SCC prevalence was 7.9 %, with the majority (77.8 %) being superficial lesions. Significant risk factors for esophageal high-grade dysplasia (HGD) and invasive cancer included tumors of the oral cavity and oropharynx and the presence of low-grade dysplasia (LGD). Overall survival (OS) was significantly shorter among patients in whom esophageal cancer was diagnosed at an advanced stage (P < .001). OS did not significantly differ between patients with HGD and early esophageal cancer versus those without esophageal cancer (P = .210) Conclusions Endoscopic screening for superficial esophageal neoplasia in patients with HNSCC improves esophageal cancer detection. Screening could potentially benefit patients with primary cancer located at the oropharynx or oral cavity. In addition, the detection of esophageal LGD indicates a need for endoscopic surveillance.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/45950
Referências
  1. Chen YF, 2016, GASTROENT RES PRACT, V2016, DOI 10.1155/2016/3741456
  2. Chen YH, 2020, CANCERS, V12, DOI 10.3390/cancers12123832
  3. Chow TL, 2009, ARCH OTOLARYNGOL, V135, P882, DOI 10.1001/archoto.2009.105
  4. Chung CS, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-154
  5. Codipilly DC., 2018, SCI REP-UK, V12, P4
  6. Dubuc J, 2006, ENDOSCOPY, V38, P690, DOI 10.1055/s-2006-925255
  7. Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4
  8. Fukuhara Tatsuma, 2010, J Clin Gastroenterol, V44, pe27, DOI 10.1097/MCG.0b013e3181b31325
  9. Gong EJ, 2016, DIS ESOPHAGUS, V29, P752, DOI 10.1111/dote.12404
  10. Kandiah K, 2017, SAUDI J GASTROENTERO, V23, P75, DOI 10.4103/1319-3767.203366
  11. Lee YC, 2009, GASTROINTEST ENDOSC, V69, P408, DOI 10.1016/j.gie.2008.05.033
  12. Leon X, 2002, ACTA OTO-LARYNGOL, V122, P765, DOI 10.1080/003655402/000028048
  13. Liang H, 2017, CANCER BIOL MED, V14, P33, DOI 10.20892/j.issn.2095-3941.2016.0093
  14. Lim H, 2015, GUT LIVER, V9, P159, DOI 10.5009/gnl13401
  15. Liu HB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128501
  16. Murakami S, 1999, DIS ESOPHAGUS, V12, P186, DOI 10.1046/j.1442-2050.1999.00045.x
  17. Oyama T, 2017, ESOPHAGUS-TOKYO, V14, P105, DOI 10.1007/s10388-016-0527-7
  18. PANOSETTI E, 1989, LARYNGOSCOPE, V99, P1267
  19. Pimentel-Nunes P, 2019, ENDOSCOPY, V51, P365, DOI 10.1055/a-0859-1883
  20. Schlemper RJ, 2000, GUT, V47, P251, DOI 10.1136/gut.47.2.251
  21. Su YY, 2013, JAMA OTOLARYNGOL, V139, P350, DOI 10.1001/jamaoto.2013.46
  22. Sunpaweravong S, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6394-6
  23. Taylor PR, 2013, CANCER EPIDEM BIOMAR, V22, P540, DOI 10.1158/1055-9965.EPI-12-1347
  24. Tseng CM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57630-6
  25. Wang GQ, 2005, GUT, V54, P187, DOI 10.1136/gut.2004.046631
  26. Wang JW, 2017, GASTROENT RES PRACT, V2017, DOI 10.1155/2017/9612854
  27. Wang WL, 2011, HEAD NECK-J SCI SPEC, V33, P77, DOI 10.1002/hed.21397
  28. Warren S., 1932, AM J CANCER, V16, P1358
  29. Watanabe S, 2017, ASIA-PAC J CLIN ONCO, V13, pE3, DOI 10.1111/ajco.12274
  30. Wei WQ, 2015, J CLIN ONCOL, V33, P1951, DOI 10.1200/JCO.2014.58.0423
  31. Yang J, 2012, WORLD J GASTROENTERO, V18, P2493, DOI 10.3748/wjg.v18.i20.2493
  32. YOKOYAMA A, 1995, CANCER, V76, P928, DOI 10.1002/1097-0142(19950915)76:6<928::AID-CNCR2820760604>3.0.CO;2-5

Coleções
Artigos e Materiais de Revistas Científicas - FM/MGT
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/24
Artigos e Materiais de Revistas Científicas - LIM/28
Artigos e Materiais de Revistas Científicas - LIM/37